Evidence position Predominantly laboratory and animal research, with very limited human data
Australia, Canada, and EU In Australia, AOD9604 is classified as a prescription-only medication by the Therapeutic Goods Administration (TGA) (Poisons Standard Appendix D lists AOD9604
However, they are banned by most competitive sports organizations including WADA and natural bodybuilding federations
First, it is an endogenous molecule: it circulates in human plasma at a concentration of roughly 200 ng/mL around age 20, declining to about 80 ng/mL by age 60, a fall that has been linked, at least associatively, to the general decline in tissue regenerative capacity with age
Drawing an accurate dose from the vial matters just as much